Physician profile
Adam Pristera
NPI 1114139599
$662.79
in general payments reported to CMS, 2019-2025
5 companies · $68.71 in 2025
The $68.71 reported for 2025 was less than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.06 · 2020: $270 · 2022: $67.04 · 2023: $72.21 · 2024: $170 · 2025: $68.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $160 · Consulting Fee: $140 · Gift: $10.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $160.44 |
| Consulting Fee | $140.00 |
| Gift | $10.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $526.85 | 2020-2025 | Invisalign, Invisalign First - Comprehensive, Itero |
| American Orthodontics Corporation | $84.62 | 2024-2025 | Master Series, Empower-Metal, Radiance |
| Patterson Companies, INC. | $20.22 | 2024 | |
| Kerr Corporation | $17.04 | 2022 | |
| Dentsply Sirona INC | $14.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Pristera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.